Weiss Asset Management LP Regeneron Pharmaceuticals, Inc. Transaction History

Weiss Asset Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $2.21 Million - $2.98 Million	-4,037 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $2.4 Million - $2.82 Million	4,037 New	4,037 $2.82 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $191,753 - $230,135	-571 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $200,500 - $233,259	571 New	571 $231,000
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $180,333 - $224,848	-571 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $204,777 - $268,341	571	571 $215,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Weiss Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Weiss Asset Management LP with notifications on news.